Penetration Testing for Philadelphia Organizations
Philadelphia's security profile is dominated by medicine in three forms that behave quite differently: delivering care, researching it, and manufacturing the therapies that come out of that research.
The health systems are the largest employers in the region, and they carry the hardest technical problem. A modern hospital network runs clinical records, imaging, laboratory systems, pharmacy, scheduling and thousands of connected medical devices in the same environment, and much of that estate cannot be patched on a normal cycle or tested intrusively without clinical risk. Ransomware against health systems has become a national pattern precisely because attackers understand that downtime here is measured in patient outcomes, not lost revenue. The useful work is therefore about containment: demonstrating how far an ordinary compromise would reach into clinical systems, and what segmentation would need to hold to stop it.
The research and therapy development cluster around University City is the second. Philadelphia is one of the founding centers of cell and gene therapy, and the material that matters, process information, batch records and trial data, retains value for years. That attracts patient, well-resourced actors rather than opportunists, and the structural weakness is collaboration: academic partners, contract manufacturers, clinical sites and instrument vendors all hold standing access into environments containing exactly the material worth stealing.
Asset management and financial services form the third concentration, with substantial fund administration in the western suburbs operating under supervisory expectations that assume an information security program with independent testing in it. Around them sit large universities holding student records and grant-funded research, chemicals and advanced manufacturing along the Delaware, a working port, and a defense supplier presence around the Navy Yard.
The recurring finding across Philadelphia engagements is not a weak perimeter. These are generally well-resourced institutions. It is that identity reaches further than anyone intended, across estates assembled over decades of mergers, affiliations and departmental autonomy.
What We Test
Philadelphia engagements are scoped around your environment rather than sold as a fixed bundle.
Internal network and Active Directory
Usually the highest-value component, and in a merged health system the most revealing. We replicate what a compromised workstation or a malicious insider could achieve: privilege escalation, lateral movement, Kerberos abuse, credential harvesting, and the route from a standard user account to domain administrator or to clinical systems. Where affiliated practices, acquired hospitals or research departments share a forest, we test that path explicitly.
Clinical and device segmentation
For health systems, we assess the boundary rather than testing connected devices intrusively: which networks reach medical devices and clinical systems, what vendor remote access exists, and whether an ordinary phishing compromise could arrive there. Active testing stays confined to environments you have explicitly agreed.
Third-party, partner and collaborator access
Standing partner and vendor accounts, guest identities in cloud tenants, laboratory and instrument systems on the corporate network, sponsor and site access into clinical systems, and the dormant credentials left behind when a program ended.
Web applications and APIs
Patient portals, clinical and research platforms, investor and client systems, and the integrations between them, tested against the OWASP Web Security Testing Guide and the OWASP API Security Top 10, covering authentication and session handling, access control across roles and tenants, object-level authorization, injection and business logic flaws.
Cloud environments
AWS, Azure and Google Cloud configuration review and exploitation: identity and access management, privilege escalation paths, exposed storage, secrets handling and the workload identities bridging cloud to on-premises, with hybrid identity between Active Directory and Entra ID examined closely.
External attack surface
Perimeter services, remote access, email infrastructure, public DNS, and the subdomains that accumulate across affiliations, departments and spin-outs. AI-augmented reconnaissance maps this continuously, and a certified operator validates what is genuinely exploitable.
Social engineering and phishing
Targeted phishing, pretext calling and physical access testing, authorized carefully and reported without singling out individuals. In academic and clinical environments, where openness and accessibility are operational values, this is often the most instructive component.
Philadelphia Compliance and Regulatory Drivers
HIPAA governs health systems, academic medical centers and affiliated practices, and the Security Rule's risk analysis expectations are difficult to satisfy credibly without testing.
FDA premarket cybersecurity expectations apply to connected medical devices and software as a medical device, covering security risk assessment, software bill of materials and evidence that risks were tested.
GLBA and SEC expectations apply to asset managers, advisers and financial institutions. FERPA covers education records across the university sector, and grant-funded research carries its own security conditions.
CMMC and NIST SP 800-171 flow down through DFARS clauses across the defense supply chain. PCI DSS applies to card handling and SOC 2 Type II to technology and services firms selling into the enterprise. Breach notification runs under the Pennsylvania Breach of Personal Information Notification Act.
How an Engagement Runs
Scoping starts with a conversation rather than a questionnaire: what you are protecting, what worries you, and what evidence you need at the end. Targets, timing, rules of engagement and success criteria are agreed in writing before anything is touched, including which clinical or laboratory environments are out of bounds.
Testing is performed by certified human operators using AI-augmented tooling for reconnaissance and coverage. Critical findings are reported the day we confirm them through an agreed channel.
The report carries an executive narrative your board or institutional leadership can act on, and technical detail your engineers can reproduce, with evidence, demonstrated impact and a prioritized remediation path. A retest of remediated items is available.
Why Philadelphia Organizations Choose StrikeCyber
Because we scope clinical and research environments conservatively by default. A test that disrupts a clinical system has failed regardless of what it discovered, and an organization that has been told otherwise by a previous provider usually recognizes the difference immediately.
Every finding is confirmed by a certified human operator, with evidence and demonstrated impact attached. AI-augmented reconnaissance and continuous attack surface validation reach coverage manual enumeration cannot. Scope and price are fixed before testing starts, and findings are prioritized by exploitability and business impact rather than raw severity score.
Related Services
Philadelphia organizations frequently combine a penetration test with:
- Red teaming, for full-spectrum adversary emulation against people, process and technology.
- Vulnerability assessments, for continuous prioritized visibility between tests.
- Maturity level assessments, for benchmarking against NIST CSF, ISO 27001 or CIS ahead of an audit or board review.
- Adversary simulation, to test whether detection and response fire against real attacker tradecraft.
You can also explore the individual testing types, including internal network, external network, web application, cloud and social engineering testing, or see the wider Pennsylvania coverage.